J.M.P.G.M. de Vos

Furumaya, A., Gumede, A., Weeda, V. B., Cillessen, S., van der Geest, L., Erdmann, J., Takkenberg, R. B., Doukas, M., de vos-geelen, J., Verheij, J., & Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG) (2026). Correct diagnosis of patients with fibrolamellar carcinoma: A Dutch nationwide study. Histopathology, 88(6), 1268-1273. https://doi.org/10.1111/his.70068

Strijk, G. J., Van Diepen, A. E., Wilmink, J. W., Rietjens, J. A. C., Haberkorn, B. C. M., Stiggelbout, A. M., Homs, M. Y. V., De Vos-Geelen, J., Van Eijck, C. H. J., & Van Eijck, C. W. F. (2026). The value of FOLFIRINOX in advanced pancreatic cancer: balancing efficacy, toxicity, and quality of life. Supportive Care in Cancer, 34(4), Article 372. https://doi.org/10.1007/s00520-026-10568-3

Graus, M. U. J. E., van Diepen, A. E., Broekman, T., van Eijck, C. W. F., van Hooft, J. E., Homs, M. Y. V., Wumkes, M. L., Wilmink, J. W., de Hingh, I. H. J. T., Valkenburg-van Iersel, L. B. J., van der Geest, L. G. M., & Vos-Geelen, J. D. (2026). Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes. European Journal of Cancer, 236, Article 116263. https://doi.org/10.1016/j.ejca.2026.116263

van der Geest, L. G., van der Mark, M., Verheij, J., Farina Sarasqueta, A., de Vos-Geelen, J., Besselink, M. G., de Meijer, V. E., de Hingh, I. H. J. T., Bonsing, B. A., de Reuver, P. R., Willemssen, F. E. J. A., Vissers, P. A. J., Visser, O., & Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group (2026). Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry. International Journal of Cancer, 158(5), 1237-1249. https://doi.org/10.1002/ijc.70145

Graus, M. U. J. E., Willems, R. A. L., Biesma, N. C., de Wilde, A. J., van den Berkmortel, F. W. P. J., Bouwense, S. A. W., Cirkel, G. A., Homs, M. Y. V., Jellema-Betten, E., Pepels-Aarts, N., van Santvoort, H. C., van Vliet, E. C. J., Wumkes, M. L., Wilmink, J. W., de Hingh, I. H. J. T., Valkenburg-van Iersel, L. B. J., de Vos-Geelen, J., & Dutch Pancreatic Cancer Group (2026). Preference versus protocol: oncology clinicians’ perspectives on central venous access for administration of chemotherapy in pancreatic cancer. ESMO Gastrointestinal Oncology, 11, Article 100311. https://doi.org/10.1016/j.esmogo.2026.100311

Broekman, T. H. T., Augustinus, S., Biesma, N., Bonsing, B. A., Cirkel, G. A., de Hingh, I. H. J. T., Homs, M. Y. V., van Hooft, J. E., van der Kolk, M., de Meijer, V. E., van Santvoort, H., de Vos-Geelen, J., Wumkes, M. L., Besselink, M. G., Wilmink, J. W., van der Geest, L. G., & Dutch Pancreatic Canc Grp (2026). Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysis. HPB, 28(3), 417-425. https://doi.org/10.1016/j.hpb.2025.12.035

Evans, E. R. E., van Poecke, N., Portela, M., Scherer-Rath, M., Weeseman, Y., Bood, Z. M., Christophe, N., Dörr, H., de Vos-Geelen, J., Beeker, A., de Klerk, G., Bras, E., Vlug, H., Bossink, F., Savelkoul, F., Timmermans, L. M., Sprangers, M. A. G., Helmich, E., & van Laarhoven, H. W. M. (2026). Drawing cancer chronicles: A qualitative study to evaluate narrative meaning-making over time and in response to a meaning-centred care intervention. PLOS ONE, 21(1 January), Article e0341150. https://doi.org/10.1371/journal.pone.0341150

Andel, P. C. M., van Goor, I. W. J. M., Biesma, N. C., Urban, L., Besselink, M. G., Bonsing, B. A., Bosscha, K., Busch, O. R., Cirkel, G. A., van Dam, R. M., van Eijck, C. H. J., Festen, S., Koerkamp, B. G., van der Harst, E., de Hingh, I. H. J. T., Intven, M. P. W., Kazemier, G., van Laarhoven, H. W. M., Liem, M. S. L., ... Dutch Pancreatic Cancer Group (2026). Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysis. European Journal of Surgical Oncology, 52(1), Article 111165. https://doi.org/10.1016/j.ejso.2025.111165

Michiels, N., Tromp, J. FK., Comes, D. J., Liem, M. NE., Groen, J. V., Besselink, M. G., Bosscha, K., Brosens, L. AA., Busch, O. R., den Dulk, M., Festen, S., van Delft, F., Koerkamp, B. G., van der Harst, E., Hermans, J., de Hingh, I. H., van Laarhoven, C. JHM., Liem, M. SL., Manusama, E., ... Dutch Pancreatic Cancer Group (2026). Short- and long-term outcomes after venous resection during left-sided and total pancreatic resection: a nationwide cohort study. HPB, 28(1), 10-18. https://doi.org/10.1016/j.hpb.2025.09.008

Lansbergen, M. F., Smith, I. P., Van Alphen, E. N., Augustinus, S., Fransen, I. J. M., Wilmink, J. W., Besselink, M. G., Molenaar, I. Q., Homs, M. Y. V., de Hingh, I. H. J. T., Bonsing, B. A., De Vos - Geelen, J., Haberkorn, B. C. M., Vissers, P. A. J., Nieuwkerk, P. T., Bijlsma, M. F., Frederix, G. W. J., van Laarhoven, H. W. M., & Dutch Pancreatic Canc Grp (2025). Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment. Health and Quality of Life Outcomes, 23(1), Article 122. https://doi.org/10.1186/s12955-025-02440-5